Redsense Medical AbNGM: REDS

REDS: Sales stable, losses widened, cash up; strong Q4 expected with new product launch

· Issued by Redsense Medical AB

Q3 2024 saw stable sales and improved gross margin, but operating losses widened amid management changes. Cash position strengthened, and a strong Q4 is anticipated with new product launches and continued US market focus.

Original document:

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

Earlier from Redsense Medical Ab

All Redsense Medical Ab news releases